🏆 Finalist — NIH Data Sharing Index (“S-Index”) Challenge

Cymon Kersch

Oregon Health & Science University

ORCID: 0000-0003-4968-9817
MedicineNeuroscienceBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 4%percentile
0.896Author DataRank

Indexed papers

1in pilot corpus
datarank_citation_only_1hop_v6· scope data_onlyMethodology
Why this DataRank?

An author's DataRank is the sum of the DataRanks of all 1 indexed paper attributed to them. A prolific author with many moderate-impact papers can outrank one with a single high-impact paper.

Author scores recompute whenever paper DataRanks are refreshed, so this number lags the underlying paper scores by at most one batch run.

Read the full methodology →

Top data-sharing exemplar

The highest-impact dataset this researcher has shared, ranked by DataRank — the single contribution doing the most to lift their data-sharing standing.

Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac104
Top 23%
0.896DataRank
Top 23%24 citations

Prakash Ambady, Matthew K. McIntyre, John Philip Tabb, Cymon Kersch, Caleb Nerison +11 more

Papers

Driven by 7 papers — median percentile 77. Top paper: “Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors”.

Safety of intra-arterial chemotherapy with or without osmotic blood–brain barrier disruption for the treatment of patients with brain tumors

Neuro-Oncology Advances(2022)10.1093/noajnl/vdac104
Top 23%
0.896DataRank
Top 23%24 citations

Prakash Ambady, Matthew K. McIntyre, John Philip Tabb, Cymon Kersch, Caleb Nerison +11 more

Transcriptional signatures in histologic structures within glioblastoma tumors may predict personalized drug sensitivity and survival

Neuro-Oncology Advances(2020)10.1093/noajnl/vdaa093
N/A
0DataRank · unranked
7 citations

Cheryl Claunch, Prakash Ambady, Elmar Bucher, Daniel L. Schwartz, Ramon Barajas +8 more

Radiation enhances the delivery of antisense oligonucleotides and improves chemo-radiation efficacy in brain tumor xenografts

Cancer Gene Therapy(2021)10.1038/s41417-021-00324-6
N/A
0DataRank · unranked
10 citations

Yingjen Jeffrey Wu, Cymon Kersch, Joshua M. Walker, Samantha Holland, Leslie L. Muldoon +2 more

Distinguishing Extravascular from Intravascular Ferumoxytol Pools within the Brain: Proof of Concept in Patients with Treated Glioblastoma

American Journal of Neuroradiology(2020)10.3174/ajnr.a6600
N/A
0DataRank · unranked
15 citations

Daniel L. Schwartz, Heather McConnell, Cymon Kersch, Xin Li, Bronwyn E. Hamilton +20 more

Deciphering spatially distinct immune microenvironments in glioblastoma using ferumoxytol and gadolinium-enhanced and FLAIR hyperintense MRI phenotypes

Neuro-Oncology Advances(2023)10.1093/noajnl/vdad148
N/A
0DataRank · unranked
5 citations

Cymon Kersch, Leslie L. Muldoon, Prakash Ambady, Christina A. Harrington, Rongwei Fu +5 more

Multiparametric magnetic resonance imaging discerns glioblastoma immune microenvironmental heterogeneity

The Neuroradiology Journal(2023)10.1177/19714009231163560
N/A
0DataRank · unranked
3 citations

Leslie L. Muldoon, Cheryl Claunch, Rongwei Fu, Daniel L. Schwartz, Soonmee Cha +4 more

Imaging Genomics of Glioma Revisited: Analytic Methods to Understand Spatial and Temporal Heterogeneity

American Journal of Neuroradiology(2024)10.3174/ajnr.a8148
N/A
0DataRank · unranked
6 citations

Minjae Kim, Jared Stoller, Ramon Barajas, Ji Eun Park, Cymon Kersch